G Simonneau

2.8k total citations · 1 hit paper
42 papers, 2.0k citations indexed

About

G Simonneau is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, G Simonneau has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Genetics. Recurrent topics in G Simonneau's work include Pulmonary Hypertension Research and Treatments (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Respiratory Support and Mechanisms (6 papers). G Simonneau is often cited by papers focused on Pulmonary Hypertension Research and Treatments (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Respiratory Support and Mechanisms (6 papers). G Simonneau collaborates with scholars based in France, United States and Switzerland. G Simonneau's co-authors include Olivier Sitbon, Ivan M. Robbins, Lewis J. Rubin, Victor F. Tapson, David B. Badesch, Maurizio Rainisio, Sébastiên Roux, Adaani Frost, Frédéric Bodin and Richard N. Channick and has published in prestigious journals such as The Lancet, Radiology and CHEST Journal.

In The Last Decade

G Simonneau

35 papers receiving 1.9k citations

Hit Papers

Effects of the dual endothelin-receptor antagonist bosent... 2001 2026 2009 2017 2001 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Simonneau France 13 1.7k 1.1k 337 255 252 42 2.0k
Maria M. Jöbsis United States 6 2.7k 1.5× 2.0k 1.8× 495 1.5× 357 1.4× 333 1.3× 6 3.0k
Linda Clayton United States 7 2.7k 1.5× 2.0k 1.8× 495 1.5× 357 1.4× 334 1.3× 10 2.9k
F Brénot France 13 1.6k 0.9× 765 0.7× 306 0.9× 401 1.6× 318 1.3× 29 2.1k
B.K.S. Sastry India 10 1.6k 0.9× 1.2k 1.1× 339 1.0× 161 0.6× 168 0.7× 18 1.8k
Hanno Leuchte Germany 27 2.4k 1.4× 1.4k 1.3× 267 0.8× 470 1.8× 122 0.5× 62 2.9k
Zeenat Safdar United States 18 2.1k 1.2× 1.4k 1.4× 346 1.0× 291 1.1× 265 1.1× 65 2.4k
Carl Arneson United States 13 2.2k 1.3× 1.7k 1.6× 478 1.4× 311 1.2× 263 1.0× 22 2.8k
Massimiliano Palazzini Italy 21 2.4k 1.4× 1.7k 1.6× 394 1.2× 310 1.2× 182 0.7× 69 2.6k
Carol E. Vreim United States 10 2.9k 1.6× 2.1k 2.0× 541 1.6× 475 1.9× 307 1.2× 12 3.5k
Takeyoshi Kunieda Japan 17 1.0k 0.6× 1.0k 0.9× 148 0.4× 239 0.9× 120 0.5× 60 1.6k

Countries citing papers authored by G Simonneau

Since Specialization
Citations

This map shows the geographic impact of G Simonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Simonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Simonneau more than expected).

Fields of papers citing papers by G Simonneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Simonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Simonneau. The network helps show where G Simonneau may publish in the future.

Co-authorship network of co-authors of G Simonneau

This figure shows the co-authorship network connecting the top 25 collaborators of G Simonneau. A scholar is included among the top collaborators of G Simonneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Simonneau. G Simonneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seferian, Andrei, Xavier Jaïs, Mitja Jevnikar, et al.. (2019). Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension. Respiratory Medicine and Research. 76. 48–53. 5 indexed citations
2.
Seeger, Werner, Yochai Adir, Joan Albert Barberà, et al.. (2014). [Pulmonary hypertension in chronic lung diseases].. PubMed. 42 Suppl 1. 142–52. 4 indexed citations
3.
Pavec, Jérôme Le, Xavier Jaïs, David Montani, et al.. (2012). Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension. European Respiratory Journal. 41(1). 96–103. 62 indexed citations
4.
Montani, David, Delphine Natali, Xavier Jaïs, et al.. (2010). Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. European Heart Journal. 31(15). 1898–1907. 238 indexed citations
5.
Degano, Bruno, Marcel Guillaume, Xavier Jaïs, et al.. (2009). HIV-Associated Pulmonary Arterial Hypertension: Survival and Prognostic Factors in the Current Therapeutic Era.. A2655–A2655.
6.
Boutet, Kim, I. Frachon, Christophe Gut‐Gobert, et al.. (2009). Fenfluramine-like cardiovascular side-effects of benfluorex. European Respiratory Journal. 33(3). 684–688. 47 indexed citations
7.
Montani, David, Barbara Girerd, Florence Coulet, et al.. (2009). Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of ACVRL1 (ALK1) Mutation.. A2659–A2659.
8.
Degano, Bruno, Grégoire Prévôt, L. Têtu, et al.. (2009). Fatal dissection of the pulmonary artery in pulmonary arterial hypertension. European Respiratory Review. 18(113). 181–185. 15 indexed citations
9.
Fartoukh, Muriel & G Simonneau. (1999). [Strategies for utilization of anticoagulants in pulmonary embolism].. PubMed. 16(5 Pt 2). 949–60. 1 indexed citations
10.
Mousseaux, Élie, J.P. Tasu, Odile Jolivet, et al.. (1999). Pulmonary Arterial Resistance: Noninvasive Measurement with Indexes of Pulmonary Flow Estimated at Velocity-encoded MR Imaging—Preliminary Experience. Radiology. 212(3). 896–902. 88 indexed citations
11.
Simonneau, G, et al.. (1998). Primary Pulmonary Hypertension Associated With the Use of Fenfluramine Derivatives. CHEST Journal. 114(3). 195S–199S. 75 indexed citations
12.
Azarian, R., Florence Parent, D. Musset, et al.. (1995). [Chronic pulmonary heart disease: therapeutic indications].. PubMed. 88(11 Suppl). 1799–805. 2 indexed citations
13.
Macchiarini, Paolo, Alain Chapelier, Jacques Cerrina, et al.. (1994). Double lung transplantation in situs inversus with Kartagener's syndrome. Journal of Thoracic and Cardiovascular Surgery. 108(1). 86–91. 34 indexed citations
14.
Azarian, R., F Brénot, Olivier Sitbon, et al.. (1994). [Pulmonary arterial hypertension of chronic thromboembolic origin; therapeutic indications].. PubMed. 87(12). 1709–13. 3 indexed citations
15.
Mallat, Ariane, Françoise Roudot‐Thoraval, Jean‐François Bergmann, et al.. (1994). Inhibition of gastric alcohol dehydrogenase activity by histamine H2‐ receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose.. British Journal of Clinical Pharmacology. 37(2). 208–211. 12 indexed citations
16.
Azarian, R., F Brénot, Olivier Sitbon, et al.. (1994). [Pulmonary arterial hypertension of chronic thrombo-embolic origin. 70 patients].. PubMed. 23(22). 1017–22. 8 indexed citations
17.
Brénot, F, P. Hervé, B Rain, & G Simonneau. (1991). [Primary pulmonary artery hypertension (data of the literature and personal experience with 25 cases in 10 years)].. PubMed. 41(17). 1560–7. 1 indexed citations
19.
Harf, A., et al.. (1981). [Gas exchange, static pressure-volume curve and positive-pressure ventilation at the end of expiration. Study of 16 cases of acute respiratory insufficiency in adults].. PubMed. 22(5). 435–41. 9 indexed citations
20.
Tenaillon, Alain, et al.. (1977). [Gayet-Wernicke encephalopathy with initial coma, hyperglycemia, acido-ketosis, and disorders of the respiratory control-system].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 128(5). 501–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026